Share |
29 September 2020


Economics of chronic diseases: a European burden

Partners of the EConDA project have published their first paper presenting preliminary results of the study.

The Economics of Chronic Diseases (EConDA) project aims to establish the best possible methods of measuring cost-effectiveness as well as develop micro-simulation models apt at projecting future burden of chronic diseases, their costs and potential savings after implementation of cost-effective interventions.

The majority of chronic diseases, including type 2 diabetes, are caused by risk factors which are mostly preventable. Effective interventions to reduce these risks are known and proven to be applicable to a variety of settings. Chronic diseases are generally developed long before the fatal outcome, meaning that many people spend a number of years in poor health. Effective prevention measures can prolong lives of individuals and significantly improve their quality of life. However, the methods to measure cost-effectiveness are  subject to much debate.

Click here to download the EConDA protocol paper on cost-effectiveness modelling.

The EConDA project has received funding from the European Commission in the framework of the Health Programme 2007-2013.

A total of sixteen leading European public health organisations participate in the project under the leadership of the UK Health Forum. Amongst them are eight members of the European Chronic Disease Alliance, WHO, OECD and two universities. As a member of the European Chronic Disease Alliance, IDF Europe is an associate partner of this project.

For more information, click here.